Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Oncol Pharm Pract ; 29(5): 1246-1250, 2023 Jul.
Article in English | MEDLINE | ID: mdl-36572997

ABSTRACT

INTRODUCTION: Tamoxifen is widely used for the treatment of hormone-responsive breast cancer. In this article, we report a case of a patient who developed hand deformities following long-term administration of tamoxifen. CASE REPORT: A 57-year-old woman, followed for invasive ductal carcinoma of the left breast under tamoxifen for 7 years, presenting joint pain with deformities in her fingers. MANAGEMENT & OUTCOME: Following the appearance of the adverse effect, tamoxifen was stopped. A series of biologic and radiologic analysis were performed in order to explain the appearance of this event. A substitution treatment was discussed and a rheumatologist's opinion was requested. DISCUSSION: Tamoxifen appears to be associated with the development of inflammatory osteoarthritis resembling rheumatoid arthritis. Possible mechanisms of such an effect are discussed.


Subject(s)
Breast Neoplasms , Tamoxifen , Humans , Female , Middle Aged , Tamoxifen/adverse effects , Antineoplastic Agents, Hormonal/adverse effects , Breast Neoplasms/pathology , Arthralgia/chemically induced
2.
Tunis Med ; 93(8-9): 532-6, 2015.
Article in French | MEDLINE | ID: mdl-26815519

ABSTRACT

BACKGROUND: Announcing cancer to a patient is not a simple task. Usually doctors fail to inform patients about the diagnosis and it is more likely in older people .The need of information in cancerous elderly is not well established. In developed countries, there is evidence that the majority of old patients are demanding exhaustive information about their disease, treatment and prognosis. AIM: In developing countries where social and cultural issues are different, perception of cancer in elderly is not well studied. Therefore we conducted a prospective study on Moroccan elderly cancerous need of information about their disease. METHODS: This is a prospective descriptive study, Conducted in the National Institute of Oncology of Morocco, cancerous patients older than 70 were included. A questionnaire was given to participants. Demographics, disease characteristics, social, economical and cultural features were recorded. RESULTS: One hundred and fifty patients responded to the questionnaire. Mean age was 73. 72.7% of patients were diagnosed in advanced stages. Illiteracy was found in 76%. 87.3% of patients did not have health insurance. All patients were Muslim, practicing in 97%. 57% ignored diagnosis. 80% didn't want to know further information about prognosis and treatment side effects. Family protection from information was found in 70%. CONCLUSION: Moroccan elderly affected with cancer are less demanding of details about their illness.Illiteracy and cultural background may play a major role, Relatives overprotection is also influencing.


Subject(s)
Needs Assessment , Neoplasms/epidemiology , Patient Education as Topic , Aged , Culture , Female , Humans , Literacy , Male , Morocco/epidemiology , Prospective Studies , Surveys and Questionnaires
3.
BMC Res Notes ; 8: 347, 2015 Aug 13.
Article in English | MEDLINE | ID: mdl-26268701

ABSTRACT

BACKGROUND: In Morocco, families play a major role in caring for elderly cancer patients. METHODS: We conducted a prospective descriptive study, in the National Institute of Oncology in Morocco. The study aimed to include family members who are caregivers for patients aged ≥70 years old. FINDINGS: After obtaining IRB approval, a total of 150 caregivers responded to the questionnaire. Mean age was 44.7 years. The majority were females (59.3%), living in urban areas (66.7%), and educated (62.7%).Offspring (sons or daughters) represented 56.7, 54% lived with their relatives in the same house. Most of the participants were married and have familial responsibilities. In relatives, anxiety was found in 79.3%, it was related to fear of losing the patient in 57% and resulted in the use of anxiolytics in 10%. Guilt feeling towards patients regarding neglecting their early symptoms was reported in 38%. Depression and anxiety were more frequent among female relatives and among those of urban origin. Obsession of dying from cancer was present in about 30% and fear of contagion was more common among those from rural areas and illiterate. Economic resources were exceeded in 78.7 and 56% have used banking credits, and sale of properties. Work lay-off was recorded in 54%. Relatives participated in treatment making decisions in 86% of patients. CONCLUSION: Even there was a great impact on elderly cancerous patients relatives, the benefits of caregiving was observed in 80%. More studies have to be conducted, especially in developing countries where the lack of resources majors the impact on family caregivers.


Subject(s)
Caregivers/psychology , Neoplasms/therapy , Adult , Aged , Anxiety , Cost of Illness , Depression , Family , Family Health , Female , Home Nursing/psychology , Humans , Male , Middle Aged , Morocco , Neoplasms/economics , Neoplasms/psychology , Parents , Prospective Studies , Stress, Psychological , Surveys and Questionnaires
4.
BMC Res Notes ; 7: 283, 2014 May 05.
Article in English | MEDLINE | ID: mdl-24886749

ABSTRACT

BACKGROUND: Fetal adenocarcinoma of the lung is a rare subtype of pulmonary adenocarcinoma with a relative estimated incidence of 0.5% or fewer of all lung cancers. Because of its extreme rarity, there have been no controlled clinical trials investigating treatment regimens for fetal adenocarcinoma and, as a result, there are no guidelines for management. CASE PRESENTATION: We report a case of a well-differentiated fetal adenocarcinoma, which is a variant of pulmonary blastoma, that is a low-grade malignancy and associated with a good prognosis. A 29-year-old Moroccan man presented with a well-differentiated fetal adenocarcinoma staged T3N0M0, who received 3 cycles of neoadjuvant chemotherapy followed by surgery, with no recurrence at 2 years follow-up. CONCLUSION: Fetal adenocarcinoma is a rare suptype of adenocarcinoma. Surgical resection is the treatment of choice for resectable disease. The role of chemotherapy in the neoadjuvant setting or adjuvant setting is not well defined.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Lung Neoplasms/drug therapy , Neoadjuvant Therapy , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/pathology , Adenocarcinoma of Lung , Adult , Biopsy , Chemotherapy, Adjuvant , Humans , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/pathology , Male , Radiography, Thoracic , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL